What were the main outcomes of Cardinal Health's 2020 Annual Meeting of Shareholders?

The main outcomes include the election of all thirteen director nominees, the ratification of Ernst & Young LLP as the independent auditor for FY2021, and the advisory approval of executive compensation. Importantly, shareholders approved lowering the threshold for calling a special meeting to 15% but rejected proposals for a 10% threshold and an independent Board Chairman.

What is the significance of lowering the threshold for calling a special meeting?

Lowering the threshold from 25% to 15% of outstanding shares makes it easier for a group of shareholders to collectively request a special meeting. This enhances shareholder activism and responsiveness, allowing for more timely discussion and potential action on important company matters outside of the annual meeting schedule.

Why were the shareholder proposals for a 10% special meeting threshold and an independent Chairman rejected?

The filing does not provide the specific reasons for the shareholder votes against these proposals. However, such rejections often occur when a majority of shareholders believe the current governance structure is adequate, or they may disagree with the specific terms or potential implications of the proposed changes as outlined in the proxy statement.

Who was appointed to the Audit Committee?

David C. Evans and Sheri H. Edison were appointed to serve on the Audit Committee of the Board of Directors. Both individuals were also elected as directors to the Board earlier in the year.

CAH 8-K: Leadership Changes & Shareholder Matters

Summary

This 8-K filing from Cardinal Health Inc. (CAH) details the outcomes of their 2020 Annual Meeting of Shareholders held on November 4, 2020, and related board appointments. Key events include the election of thirteen nominees to the Board of Directors, with all nominees receiving substantial support. Additionally, shareholders ratified the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending June 30, 2021, and approved the compensation of named executive officers on an advisory basis. The filing also highlights significant shareholder votes on corporate governance proposals. Shareholders approved an amendment to the Company's Code of Regulations to lower the threshold for requesting a special meeting to 15% from 25%, indicating a move towards greater shareholder responsiveness. However, two shareholder proposals regarding further lowering the special meeting threshold to 10% and requiring an independent Chairman of the Board were not approved.

Key Highlights

1All thirteen director nominees were elected to the Board of Directors with strong shareholder support, ensuring continuity in leadership until the 2021 Annual Meeting.
2Ernst & Young LLP was ratified as Cardinal Health's independent auditor for the fiscal year ending June 30, 2021, providing assurance on financial reporting.
3Shareholders approved, on an advisory basis, the compensation of the company's named executive officers, signaling general confidence in executive pay structures.
4A significant governance change was approved: the threshold for shareholders to call a special meeting was lowered from 25% to 15% of outstanding shares.
5Shareholder proposals to further reduce the special meeting threshold to 10% and to mandate an independent Chairman of the Board were both rejected by shareholders.
6David C. Evans and Sheri H. Edison were appointed to the Audit Committee of the Board.
7The company filed an amendment to its Restated Code of Regulations as Exhibit 3.2, reflecting the approved changes to special meeting provisions.

CARDINAL HEALTH INC 8-K/A Report, Executive Changes (Nov 9, 2020)

Summary

Key Highlights

Frequently Asked Questions